Upcoming webinar: WHO Launches New Clinical Trial Guidance –
|
Thank you for visiting The Global Health Network, please take a moment to read this important message. As you know, our aim is to enable equity in access to research knowledge and this is successfully delivering support and training to 1000’s of research teams all over the world. But we need your support!. If you have benefited from this research skills and knowledge sharing facility, please help us sustain this remarkable and unique provision of information for those who could otherwise not access such support and training. We would be really grateful if you could make a donation or ask your employer or organisation to contribute to the costs of maintaining this platform and the generation of new contents for all users. Just a small contribution from everyone who can afford to pay would keep this available for those who cannot. Thank you, we really appreciate your part in this community effort to better equity in global health research.
ISoP Africa Chapter is organizing its first in-person meeting in July 2024, which aims to foster collaboration and knowledge exchange to enhance pharmacovigilance practices within the continent. Read more
Developed for national regulatory authorities, pharmaceutical manufacturers, healthcare professionals, and procurement agencies, the compendium is a key tool for upholding the globally acceptable standards of good manufacturing practices (GMP) and inspections. Read more
Quant & qual approaches to evaluation of benefit-risk incl. visual presentations to improve transparency & understanding among stakeholders, including patients. Read more
This WHO Medical Product Alert refers to four substandard products, identified in The Gambia and reported to WHO in September 2022. Substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore "out ... Read more
Can't find what you're looking for? Try browsing our Featured News Sources. You can also find new previously featured on our home page in our News Archive! Read more
This module from the Toolkit for research and development of paediatric antiretroviral drugs and formulations introduces the concepts of pharmacovigilance and adverse drug reactions, discusses the burden of adverse drug reactions for children and explains the importance of pharmacovigilance in the context of antiretroviral therapy.
The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data. In order to fill the ...